Necrolytic migratory erythema as the first manifestation of glucagonoma
- PMID: 22970401
- PMCID: PMC3434377
- DOI: 10.1155/2012/974210
Necrolytic migratory erythema as the first manifestation of glucagonoma
Abstract
Necrolytic migratory erythma (NME) as a rare skin disorder that can affected Perineum, distal extremities, lower abdomen and face are the most commonly affected sites.It can be as a part of Glucagonoma syndrome that is defined as an association of glucagonoma with NME, hyperglucagonemia, glucose intolerance, anemia and weight loss. Here, Authors describe a woman admitted to the dermatology ward with NME which was later found to be associated with glucagonoma and multiple hepatic lesions.
Similar articles
-
Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.World J Surg Oncol. 2014 Jul 17;12:220. doi: 10.1186/1477-7819-12-220. World J Surg Oncol. 2014. PMID: 25029913 Free PMC article.
-
Necrolytic migratory erythema and glucagonoma rising from pancreatic head.Pancreatology. 2013 Jul-Aug;13(4):455-7. doi: 10.1016/j.pan.2013.03.011. Epub 2013 Mar 30. Pancreatology. 2013. PMID: 23890147
-
Necrolytic migratory erythema and pancreatic glucagonoma.Biomedica. 2016 Jun 3;36(2):176-81. doi: 10.7705/biomedica.v36i3.2723. Biomedica. 2016. PMID: 27622478
-
A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.Int J Dermatol. 2018 Jun;57(6):642-645. doi: 10.1111/ijd.13947. Epub 2018 Feb 16. Int J Dermatol. 2018. PMID: 29450880 Review.
-
The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.Eur J Endocrinol. 2004 Nov;151(5):531-7. doi: 10.1530/eje.0.1510531. Eur J Endocrinol. 2004. PMID: 15538929 Review.
Cited by
-
Unremitting chronic skin lesions: a case of delayed diagnosis of glucagonoma.J Community Hosp Intern Med Perspect. 2019 Nov 1;9(5):425-429. doi: 10.1080/20009666.2019.1671574. eCollection 2019. J Community Hosp Intern Med Perspect. 2019. PMID: 31723389 Free PMC article.
-
Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.World J Surg Oncol. 2014 Jul 17;12:220. doi: 10.1186/1477-7819-12-220. World J Surg Oncol. 2014. PMID: 25029913 Free PMC article.
-
Case of delayed diagnosis of necrolytic migratory erythema.Clin Case Rep. 2021 Dec 11;9(12):e05179. doi: 10.1002/ccr3.5179. eCollection 2021 Dec. Clin Case Rep. 2021. PMID: 34938555 Free PMC article.
-
Case report: Surgical treatment and literature review of a recurrent case of glucagonoma.Front Oncol. 2024 Aug 26;14:1437102. doi: 10.3389/fonc.2024.1437102. eCollection 2024. Front Oncol. 2024. PMID: 39252948 Free PMC article.
References
-
- Becker SW, Brennan BB. Benign and malignant cutaneous tumors in the elderly. Archives of Dermatology. 1961;83:262–271. - PubMed
-
- McGavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin ME. A glucagon-secreting alpha-cell carcinoma of the pancreas. The New England Journal of Medicine. 1966;274(25):1408–1413. - PubMed
-
- Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B. A glucagonoma syndrome. The Lancet. 1974;2(7871):1–5. - PubMed
-
- van Beek AP, de Haas ERM, van Vloten WA, Lips CJM, Roijers JFM, Canninga-van Dijk MR. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. European Journal of Endocrinology. 2004;151(5):531–537. - PubMed
LinkOut - more resources
Full Text Sources